Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains Leia mais sobre Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains
Benznidazole-induced genotoxicity in diploid cells of Aspergillus nidulans Leia mais sobre Benznidazole-induced genotoxicity in diploid cells of Aspergillus nidulans
Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components? Leia mais sobre Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects Leia mais sobre Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease Leia mais sobre The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment Leia mais sobre Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment
Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice Leia mais sobre Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice
Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras Leia mais sobre Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras
In vitro and in vivo experimental models for drug screening and development for Chagas disease Leia mais sobre In vitro and in vivo experimental models for drug screening and development for Chagas disease
Benznidazole levels in blood vary with age in rats Leia mais sobre Benznidazole levels in blood vary with age in rats
A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention Leia mais sobre A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease Leia mais sobre Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole Leia mais sobre Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole
Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole Leia mais sobre Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial Leia mais sobre Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial
Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations Leia mais sobre Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations
Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach* Leia mais sobre Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*
Critical analysis of Chagas disease treatment in different countries Leia mais sobre Critical analysis of Chagas disease treatment in different countries
Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells Leia mais sobre Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells
Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved* Leia mais sobre Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved*
The impact of probiotic administration on experimental in vitro and in vivo infection by Trypanosoma cruzi Leia mais sobre The impact of probiotic administration on experimental in vitro and in vivo infection by Trypanosoma cruzi
Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population Leia mais sobre Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population
